The CD19+ B-cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low-grade lymphoma-Reference-Cited by-同舟云学术

The CD19+ B-cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low-grade lymphoma

Published:2002-03 Issue:3 Volume:116 Page:695-701
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Straka Christian,Oduncu Fuat,Drexler Eva,Mitterer Manfred,Schnabel Brigitte,König August,Brack Norbert,Nerl Christoph,Emmerich Bertold

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.0007-1048.2001.03313.x/fullpdf

Reference33 articles.

1. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma;Bastion;Blood,1995

2. Detection of clonal excess in lymphoproliferative disease by k/1 analysis: Correlation with immunoglobulin gene DNA rearrangement;Berliner;Blood,1986

3. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma;Bierman;Journal of Clinical Oncology,1997

4. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting;Corradini;Blood,1997

5. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery;Dreger;Bone Marrow Transplantation,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Monitoring of Lymphoma;The Lymphomas;2006

2. Responsiveness to G-CSF before leukopenia predicts defense to infection in high-dose chemotherapy recipients;Blood;2004-10-01

3. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma;Bone Marrow Transplantation;2004-05-31

4. Current Awareness in Hematological Oncology;Hematological Oncology;2002